Last reviewed · How we verify
NCT04362397: FoCo
FoCo: Evaluating a Training to Increase Attention and Awareness of Healthcare Professionals
NA trial testing FoCo in Attention in 190 participants. Completed in 20 December 2020.
20 May 2020
Quick facts
| Lead sponsor | Hospital Israelita Albert Einstein |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | crossover |
| Masking | double |
| Primary purpose | health services research |
| Enrollment | 190 |
| Start date | 20 August 2019 |
| Primary completion | 20 May 2020 |
| Estimated completion | 20 December 2020 |
| Sites | 1 location across Brazil |
Drugs / interventions tested
- FoCo
- No intervention
Conditions studied
- Attention — all drugs for Attention →
- Self-compassion — all drugs for Self-compassion →
Sponsor
Hospital Israelita Albert Einstein
Who can join
Adults 18 to 65, any sex, with Attention or Self-compassion. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Introduction: A significant increase in the risk of injury and illness at work has been associated with fatigue, stress, haste, distraction, emergency situations, excessive noise, complex procedures and anger among other factors. Most of these factors are related to the lack of attention to work in progress, which can be improved by training attention and awareness during daily activities, as it would encourage a resumption of focus on the task at hand and the possible risks associated with it. . The primary objective of this project is to evaluate the effects of training to increase attention and awareness for daily activities - FoCo - outlined for healthcare professionals in their work schedule. Method: Health professionals from 18 to 60 years of age, of both sexes, will participate in the study, working in 3 units, one in the care of patients in a Emergency Care Unit (UPA), in an Elderly Residential and in a Center. Intensive Care (ICU). In the UPA will be included 25 professionals in group A and 25 in group B; In the Residential of Elderly, 40 professionals will be included in group A and 40 professionals in group B; In the ICU will be included 30 professionals in group A and 30 in group B. They will be randomized in both groups. Group A will receive training in the FoCo program and group B will be a waiting group. After a period of one month, group B will receive training in FoCo and group A will be instructed to continue on their own to apply FoCo in their daily lives (Fig.1). Participants will be evaluated before, after one month and after two months. Expected Outcomes: After training, an increase in mindful, attention and awareness scale, self-compassion scale, positive affect, speed of digit and symbol test is expected. It is also expected to reduce negative affects, perceived stress and an increased perception of possible incidents.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
An Intervention to Increase Situational Awareness and the Culture of Mutual Care (Foco) and Its Effects During COVID-19 Pandemic: A Randomized Controlled Trial and Qualitative Analysis.
Kozasa EH, Lacerda SS, Polissici MA, Coelho RDS, et al · · 2020 · cited 3× · PMID 33324250 · DOI 10.3389/fpsyt.2020.570786
Verify or expand the search:
- PubMed search for NCT04362397
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Attention
Currently open trials in the same condition.
- NCT07266909 — Impact of Attentional Tunelling on a Population of French Practitioners · recruiting
- NCT07408180 — Exploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Table · NA · active not recruiting
- NCT06837246 — A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population · NA · recruiting
- NCT06587113 — An Investigation of Attentional and Inhibitory Processes During Active Visual Search in Humans · NA · recruiting
- NCT06248268 — Neuropsychological Patterns of Suicide Ideators and Suicide Attempters · recruiting
Other Hospital Israelita Albert Einstein trials
Trials by the same sponsor.
- NCT07447674 — ED Post-Discharge Digital Follow-Up: A Communication Comparison · NA · not yet recruiting
- NCT07398222 — Gastric Content in Fasting Volunteers and in Tirzepatide Users: an Observational and Cross-sectional Study · recruiting
- NCT07233837 — Hydrogen Peroxide and Ultraviolet Light for Disinfecting Surfaces in Intensive Care Units · NA · recruiting
- NCT06726707 — COPPER: A Trial Evaluating Copper-based Products for Incontinence-associated Dermatitis · Phase 2, PHASE3 · withdrawn
- NCT07112846 — Prospective Clinical Registry for Evaluation of Exanthematous Infections and Coinfections · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04362397 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 9 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Hospital Israelita Albert Einstein
- Last refreshed: 11 February 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04362397.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing